Selank and Cognitive Function in Preclinical Models of Alcohol Exposure

In a 2019 study conducted by Kolik et al., researchers investigated the effects of the synthetic peptide Selank, an analogue of the endogenous peptide tuftsin, on memory function and neurotrophin levels in adult rats exposed to chronic ethanol consumption. The study aimed to evaluate whether Selank could prevent or reduce memory deficits induced by prolonged ethanol intake and to explore potential mechanisms involving brain-derived neurotrophic factor (BDNF).
According to the research methods described, outbred male rats were provided with 10% ethanol as their only source of fluid for a period of 30 weeks to model chronic ethanol exposure and its impact on cognitive function (Kolik et al., 2019). Selank was administered intraperitoneally at a dose of 0.3 mg/kg per day for seven consecutive days. Cognitive performance was assessed using the object recognition test, a validated behavioral paradigm that measures the ability of rodents to distinguish between familiar and novel objects, reflecting memory and attention processes.
The results reported by the researchers showed that in rats not exposed to ethanol, Selank produced a statistically significant cognitive-stimulating effect in the object recognition test (p < 0.05). Furthermore, in animals that had undergone chronic ethanol exposure, Selank prevented the development of ethanol-induced memory and attention impairments that typically occur during alcohol withdrawal (p < 0.01). In ex vivo biochemical analyses, the study found that chronic ethanol exposure increased BDNF content in the hippocampus and frontal cortex, and Selank administration effectively prevented these ethanol-associated increases (p < 0.05). The authors interpreted these findings as indicating a potential neuroprotective effect of Selank linked to modulation of neurotrophin mechanisms, particularly BDNF production.
The study by Kolik et al. (2019) contributes to the scientific understanding of how regulatory peptides like Selank may influence cognitive processes and neurochemical pathways in the context of chronic substance exposure. Although these results derive from a rodent model and cannot be directly extrapolated to humans, the observed effects on memory performance and neurotrophin regulation support further investigation into the peptide’s neurobiological actions.

Important Notice
This content is provided for educational and informational purposes only. The research discussed relates exclusively to laboratory and scientific investigation. No claims are made regarding biological activity, therapeutic use, or outcomes. Compounds referenced are not intended for human or veterinary use.

Sources
Kolik L. G. et al. (2019). Selank, peptide analogue of tuftsin, protects against ethanol-induced memory impairment by regulating BDNF content in the hippocampus and prefrontal cortex in rats. Bulletin of Experimental Biology and Medicine.